WTNA
VRTX icon

Wilmington Trust National Association’s Vertex Pharmaceuticals VRTX Stock Holding History

Wilmington Trust National Association’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-3,079
Closed -$217K – 626
2014
Q1 		$217K Buy
+3,079
New +$244K 0.01% 556

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Wilmington Trust National Association's VRTX Position: Q2 2014 in Review

Wilmington Trust National Association sold out of Vertex Pharmaceuticals (VRTX) in Q2 2014, closing a stake of 3,079 shares — an estimated $217K sold.

Wilmington Trust National Association first reported a position in VRTX in Q1 2014 and held it in 1 quarter. The position peaked at $217K in Q1 2014. 411 funds tracked by Wall St. Rank hold VRTX as of Q2 2014.

  • Wilmington Trust National Association reported no remaining Vertex Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • Wilmington Trust National Association sold 3,079 Vertex Pharmaceuticals shares in Q2 2014, an estimated $217K.
  • Wilmington Trust National Association first reported a position in Vertex Pharmaceuticals in Q1 2014 and held it in 1 quarter.
  • Wilmington Trust National Association's Vertex Pharmaceuticals position peaked at $217K in Q1 2014.
  • 411 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2014.

Based on Wilmington Trust National Association's 13F filing for Q2 2014, filed 13 Aug 2014.